Results 271 to 280 of about 5,563,712 (386)
Psychosocial consequences of xylazine and implications for harm reduction services. [PDF]
Plesons M +10 more
europepmc +1 more source
IqgC is a RasGAP from Dictyostelium discoideum. IqgC binds RasG via its RasGAP domain and deactivates it on macroendocytic cups, thereby suppressing the uptake of fluid and particles. IqgC has a positive effect on cell‐substratum adhesion, and its RGCt domain is required for recruitment to ventral foci.
Vedrana Filić +3 more
wiley +1 more source
Increasing opportunities for community input in harm reduction program development using iterative engagement. [PDF]
Wagner NM +9 more
europepmc +1 more source
CDT1 is an essential protein for DNA replication licensing that loads the MCM complex, the eukaryotic replicative DNA helicase, onto replication origins. Overexpression of CDT1 induces cell cycle arrest at the S phase. Here we showed CDT1 inhibits the progression of replication forks by interacting with the MCM complex, leading to the stalling and ...
Takashi Tsuyama +7 more
wiley +1 more source
Reply of the authors: Positioning human chorionic gonadotropin therapy for androgen users within a harm reduction framework. [PDF]
Smit DL, Verdegaal T, Bond P.
europepmc +1 more source
A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
We developed a general enzyme kinetic model that integrates these six basic inhibition mechanism onto a single one. From this model, we deduced a general enzyme kinetic equation that through modulation of simple parameters, γ (the relative inhibitor affinity for two binding sites) and β (the reactivity of the enzyme–substrate–inhibitor complex), is ...
Rafael S. Chagas, Sandro R. Marana
wiley +1 more source
Beyond traditional models: a content analysis exploring the applicability of harm reduction in eating disorder care. [PDF]
Gilmartin T +3 more
europepmc +1 more source

